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Brucella spp. are intracellular bacterial pathogens that cause infection in domestic and
wild animals. They are often used as model organisms to study intracellular bacterial
infections. Brucella VirB T4SS is a key virulence factor that plays important roles in
mediating intracellular survival and manipulating host immune response to infection. In
this review, we discuss the roles of Brucella VirB T4SS and 15 effectors that are proposed
to be crucial for Brucella pathogenesis. VirB T4SS regulates the inflammation response
and manipulates vesicle trafficking inside host cells. VirB T4SS also plays crucial roles in
the inhibition of the host immune response and intracellular survival during infection. Here,
we list the key molecular events in the intracellular life cycle of Brucella that are potentially
targeted by the VirB T4SS effectors. Elucidating the functions of these effectors will help
clarify the molecular role of T4SS during infection. Furthermore, studying the effectors
secreted by Brucella spp. might provide insights into the mechanisms used by the
bacteria to hijack the host signaling pathways and aid in the development of better
vaccines and therapies against brucellosis.
Keywords: Brucella, type IV secretion, intracellular survival, effector, signaling pathway
INTRODUCTION
Brucella spp. cause brucellosis in domestic and wild animals. Their primary hosts include sheep,
cattle, swine, dogs, camels, and desert woodrats (Martirosyan et al., 2011; Bargen et al., 2012).
Humans are secondary or accidental hosts and usually contract brucellosis through contact with
infected animals or animal products (Atluri et al., 2011; Bargen et al., 2012). Brucellosis is a chronic
disease and may last several weeks or months. If it is not treated effectively, the disease can lead
to pathologies in the liver, spleen, lymph nodes, bone marrow, reproductive tract, and skeletal
system (Atluri et al., 2011). Some complications, including arthritis, liver abscess, epididymo-
orchitis, neurobrucellosis, and endocarditis, often tend to relapse, resulting in long-term disability
and suffering (Colmenero et al., 1996; Franco et al., 2007).
In natural hosts, Brucella can penetrate the mucous membranes of the reproductive, respiratory,
and digestive tracts and the conjunctiva; in humans, the most common sites of entry are the
respiratory and digestive tracts (Atluri et al., 2011; Bargen et al., 2012). Once the bacteria break
the mucosal barrier, they enter the regional lymph nodes and disseminate through the body (Atluri
et al., 2011). Inside the host, the bacteria reside in the macrophages for several days and replicate to
high numbers asymptomatically (Martirosyan et al., 2011). Therefore, elucidating the mechanisms
involved in their intracellular survival and their ability to evade host immunity is crucial for
understanding the pathogenesis of Brucella spp., which are used as model organisms to study
intracellular bacterial infections.
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On entering the host cells, the bacteria interact with the
early and late endosomes and acquire several markers, including
Rab5, early endosome antigen (EEA) 1, and Rab7, resulting
in the formation of a “Brucella-containing vacuole” (BCV)
(Pizarro-Cerdá et al., 1998; Chaves-Olarte et al., 2002; Celli
et al., 2003; Starr et al., 2008; Lee et al., 2013). The BCVs
then fuse rapidly with the lysosome in a controlled manner, as
suggested by the presence of the lysosomal markers, lysosomal-
associated membrane protein (LAMP), and CD63, but not
the luminal lysosome enzyme, cathepsin D, on the surface of
bacteria (Pizarro-Cerdá et al., 1998; Celli et al., 2003; Starr
et al., 2008). In this transient stage, most of the contents
of the BCVs are subjected to phagolysosomal degradation,
and 90% of internalized Brucella are killed by the action of
hydrolyzing enzymes (Celli et al., 2003). However, the remaining
10% evade the host killing mechanisms through an unknown
mechanism that probably involves the acidification of the
BCVs, subsequent triggering of the virB operon [which encodes
the type IV secretion system (T4SS)], and release of a large
variety of effectors into the host cells’ cytosol (Boschiroli et al.,
2002). The bacteria then traffic and arrive at the endoplasmic
reticulum (ER). Within the ER, the bacteria survive and establish
their replicative niche, and multiply to large numbers (Celli
et al., 2003). However, the ER is not the final site of this
intracellular journey; recent studies have shown that autophagy-
like vacuoles provide a replication-permissive compartment for
Brucella following the ER stage (Starr et al., 2012). Because the
“Brucella-replicating organelle” possesses autophagic features, it
is also called the autophagic BCV (aBCV). The formation of
the aBCV is essential for the completion of the intracellular
lifecycle of Brucella and for cell-to-cell spreading (Starr et al.,
2012).
Although several studies have attempted to elucidate the
pathogenesis of Brucella, the components that are responsible for
their virulence and their ability to establish systemic infection
have not been identified. For a long time, it was thought that
Brucella spp. lacked the characteristic virulence factors that are
present in other bacteria (Fugier et al., 2007). However, in recent
years, various virulence factors that are essential for infection,
including lipopolysaccharide (LPS) (Lapaque et al., 2005), β-
cyclic glucan (Arellano-Reynoso et al., 2005; Martirosyan et al.,
2012), BvrS/BvrR (Guzman-Verri et al., 2002; Martín-Martín
et al., 2012), outer membrane proteins (Omps) (Lim et al., 2012;
Vizcaíno and Cloeckaert, 2012), BmaC (Posadas et al., 2012),
MucR (Mirabella et al., 2013), SagA (Del Giudice et al., 2013),
BtaE (Ruiz-Ranwez et al., 2013), BacA (Martín-Martín et al.,
2012), and BetB (Lee et al., 2014), have been identified in Brucella
VirB. T4SS is another key virulence factor that plays important
roles in mediating intracellular survival and manipulating host
immune response to infection. Many studies have elucidated
various aspects of VirB T4SS from Brucella spp., such as its
genetic organization, structure, functions, and transcriptional
regulation. Some studies have used T4SS as targets for small
molecular inhibitors (Paschos et al., 2011; Smith et al., 2012).
T4SS functions in the translocation of effector proteins across
bacterial and host membranes into the host cytosol. Therefore,
to understand the functions of T4SS, it is important to identify
these effectors. Recent studies have identified 15 effectors that are
secreted by Brucella in a T4SS-dependent manner. In this review,
we discuss the roles of Brucella T4SS and its 15 effectors, as
well as the associations between bacterial phenotype and effector
functions.
BRUCELLA TYPE IV SECRETION SYSTEM
Organization, Structure, and Regulation
In Brucella, T4SS is encoded by the virB operon, which consists
of 12 genes (virB1–12) located on chromosome II. Transcription
of the virB operon is controlled by the promoter upstream
of virB1 (O’Callaghan et al., 1999; Sieira et al., 2000). The
virB operon was first identified in B. suis. Subsequently, it was
found to be highly conserved in all Brucella spp. for which
genomic sequences were available, indicating a potentially critical
role for this operon (O’Callaghan et al., 1999). Although the
structure of T4SS from Brucella is unknown, the architecture of
two closely related T4SSs, one from Agrobacterium tumefaciens
(VirB/D4 system) and the other from Escherichia coli (encoded
on the R388 conjugative plasmid), has been examined. The
T4SS apparatus is a large macromolecular complex comprising
12 subunits. The complex can be divided into five parts: the
stretching needle complex (composed of VirB2), the core/outer
membrane complex (composed of VirB7, VirB9, and VirB10),
the linking stalk (probably composed of fragments from VirB5
or VirB10), the inner membrane complex (composed of VirB3,
VirB4, VirB6, VirB8, and the N-terminus of VirB10), and the
ATPases/energy center (consisting of VirB4 andVirB11) (Fronzes
et al., 2009; Low et al., 2014; Trokter et al., 2014). Except for
VirB1, VirB7, and VirB12, all the other subunits play crucial roles
in the virulence of Brucella (as inferred from studies involving
mice), which may reflect their status in the whole machinery
(Comerci et al., 2001; den Hartigh et al., 2004, 2008; Sun et al.,
2005).
The underlying molecular mechanisms involved in the
initiation of T4SS assembly are still unknown; however, some
intracellular signals are thought to be critical for inducing the
assembly of T4SS. Several transcriptional regulators may be
involved in this process. The low pH condition that occurs
within the BCV (as a result of acidification when fusing
with the lysosome) probably serves as the key signal that
induces the upregulation of the virB operon in the bacteria
(Porte et al., 1999; Boschiroli et al., 2002; Köhler et al., 2002).
Regulators that regulate the expression of the virB operon include
vacuolar hijacking Brucella regulator VjbR (Arocena et al., 2010),
Brucella luxR-like regulator (BlxR) (Rambow-Larsen et al., 2008),
histidine utilization regulator (HutC) (Sieira et al., 2010), the
two-component regulatory system BvrR/BvrS (López-Goñi et al.,
2002; Martínez-Núñez et al., 2010), RelA/SpoT homolog (Rsh)
(Dozot et al., 2006), MarR-like sodium deoxycholate-responsive
activator (MdrA) (Sieira et al., 2012), Brucella quorum-sensing
regulator (BabR) (Caswell et al., 2012), and integration host factor
(IHF) (Sieira et al., 2004). However, their exact roles in the
induction and assembly of T4SS during infection remain to be
evaluated.
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Role of T4SS during Infection
Since its identification, T4SS from Brucella has been studied
extensively. Several in vitro and in vivo studies have improved
our understanding of the phenotypes, including long-term
survival within the host, immune inhibition, and the underlying
mechanism of action of T4SS. Most of these studies have
concentrated on four critical aspects of Brucella infection:
phenotypes of the infected animals, surviving ability in cultured
cells, utilization of the host vesicle trafficking pathway, and
regulation of the host inflammatory response. The results
indicate that T4SS plays crucial roles in the inhibition of the
host innate immune response and in intracellular survival during
infection.
In animal models, mainly mice and goats, screening of genes
involved in Brucella virulence by signature-tagged mutagenesis
(STM) led to the identification of T4SS as the crucial factor
required to establish successful infection in vivo (Hong et al.,
2000; Lestrate et al., 2000, 2003; Kahl-McDonagh et al., 2006;
Zygmunt et al., 2006). In these studies, screening for genes
essential for the acute phase of infection did not identify T4SS;
however, screening for genes required for chronic persistence
identified T4SS as the virulence determinant (Hong et al., 2000;
Lestrate et al., 2003). Consistent with these results, subsequent
analysis of the kinetics of infection in mice and calves revealed
that T4SS is not needed for initial systematic colonization within
the spleen, liver, kidney, and lungs, but is required for chronic
persistence (Rajashekara et al., 2005; Rolán and Tsolis, 2007;
Rossetti et al., 2013). In goats, a similar screening experiment
suggested that T4SS is involved in bacterial survival in vivo.
Another study reported that, unlike wild-type B. melitensis 16M,
attenuated B. melitensis lacking virB2 does not cause abortions
or colonize fetal tissues in pregnant goats (Kahl-McDonagh
et al., 2006; Zygmunt et al., 2006). Recent studies on T4SS in
two less virulent strains, B. ovis and B. microti, revealed that
T4SS-deficient strains are significantly attenuated in both the
early and late stages of infection (Hanna et al., 2011; Sá et al.,
2012).
In cultured cells, including THP1, J774, dendritic cells,
murine bone marrow-derived macrophages (BMMs), primary
human monocytes, and HeLa cells, T4SS has been shown to
be essential for the intracellular growth of Brucella during
infection (O’Callaghan et al., 1999; Foulongne et al., 2000;
Pizarro-Cerdá et al., 2000; Sieira et al., 2000; Comerci et al.,
2001; Delrue et al., 2001; Celli et al., 2003; Salcedo et al., 2008;
den Hartigh et al., 2008). Screening for the intracellular growth
ability of Brucella mutants in HeLa and THP1 cells revealed
that the disruption of T4SS leads to impaired intracellular
survival, thereby demonstrating the importance of this secretion
machinery in vitro (Foulongne et al., 2000; Delrue et al., 2001).
Among the proteins that comprise the T4SS apparatus, VirB2–
6 and VirB8-11, were found to be essential for the survival and
replication of Brucella within host cells (Guzman-Verri et al.,
2002; Celli et al., 2003; Fronzes et al., 2009; Lee et al., 2013;
Trokter et al., 2014), indicating the importance of the integrity
of this secretion apparatus and the differing roles of its various
components. T4SS-deficient mutants exhibited complete loss of
the ability to grow within cells, in vitro; however, they exhibited
no attenuation in the initial systematic spreading stage, albeit a
diminished replicating ability during the later stage was observed
in vivo. This suggests that, in the initial invasion stage of an
in vivo infection, bacterial survival does not rely on T4SS. This
may be attributed to the extracellular localization of the bacteria
and the favorable microenvironment. These aspects need to be
studied in more detail in the future.
To elucidate the mechanism by which T4SS mediates the
intracellular survival ability of Brucella, VirB10 polar mutants,
which lacked the virB10 gene and were therefore, deficient in
T4SS, were used. The results revealed that T4SS-deficient Brucella
still invaded host cells and interacted with the early and late
endosomes in a manner similar to that by wild-type bacteria,
as suggested by the acquisition of the early and late endosome
markers (EEA1 and LAMP1, respectively) by the BCVs (Delrue
et al., 2001; Celli et al., 2003). However, unlike wild-type Brucella,
BCVs of the mutant bacteria did not exclude LAMP1 over time,
and remained LAMP1-positive. Therefore, these mutants were
engulfed by lysosomes and eventually targeted for degradation
(Comerci et al., 2001; Delrue et al., 2001; Celli et al., 2003).
Thus, unlike wild-type Brucella, the T4SS-deficient mutants did
not complete their intracellular lifecycle, which involves escaping
from the late endosome, reaching the ER and establishing the
replicating niche, and escaping from the ER to utilize autophagic
vacuoles for survival (Starr et al., 2012). Therefore, what happens
to the BCVs within the late endosome/lysosome is very critical,
and determines the fate of intracellular Brucella. This divergence
may depend on the induction of the virB operon and subsequent
delivery of the effectors into the host cytosol. The signals
that trigger the induction may originate from the environment
around Brucella, such as acidification during BCV fusion with the
late endosome/lysosome (Pizarro-Cerdá et al., 1998; Starr et al.,
2008).
Brucella use the stealth strategy to avoid immune recognition
by the host, and elicit a much lower immune response compared
to other bacterial infections, such as those caused by Salmonella
(Barquero-Calvo et al., 2007). Although T4SS may play a role in
regulating the host immune response, the molecular mechanism
underlying this regulation is unclear. Some studies have indicated
that T4SS is required for Brucella to elicit relatively low levels of
immune responses (Rolán and Tsolis, 2007, 2008; Rolán et al.,
2009). Conversely, experiments performed on other bacteria have
indicated roles for T4SS in inhibiting host immune responses,
as evidenced by the fact that T4SS-deficient mutants generally
induce a stronger immune response in the hosts than wild-type
strains (Luo, 2012; van Schaik et al., 2013). The phenotype of the
infected cells suggested that T4SS-deficient Brucella are quickly
degraded in the lysosomes, before they can ignite an immune
response. On the other hand, wild-type Brucella activate the host
immune response at a later stage in their intracellular lifecycle.
Another possibility is that the effectors secreted by T4SS have
inflammation-inhibitory activities within host cells. Therefore,
we believe that the loss of a functional T4SS may lead to impaired
effector secretion and upregulated immune responses.
Like formany other bacteria, T4SS is essential for the virulence
of Brucella infections, in both animal models and cultured
cells. The cellular and molecular mechanisms underlying this
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virulence may include hijacking the vesicle trafficking pathway
and manipulating the innate and adaptive immune responses
of the host. T4SS secretes effectors into host cells. These
effectors then target various host mechanisms and perpetuate
the infection. Therefore, identifying the effectors secreted
by Brucella through the T4SS machinery and determining
their target host pathways are critical for understanding their
pathogenesis.
Molecular Events that are Potentially
Targeted by Brucella T4SS Effectors
To date, 15 T4SS effectors have been identified in Brucella.
The phenotypes presented by T4SS-deficient mutants and
studies on some well-known T4SS effectors from other bacteria
suggest that, in Brucella, T4SS effectors might function in
the following molecular events associated with infection: (1)
excluding markers of late endosome or lysosome, (2) acquiring
ER markers, (3) interacting with secretory pathways, (4)
acquiring markers for autophagosomes, (5) resisting the harsh
intracellular environment, and (6) regulating the activation
of vital immune pathways (Figure 1). However, their exact
mechanisms of action have not been clarified. Every event may
be targeted by one or more effectors, and an effector may act
on one or more processes. In addition, the effectors may exhibit
overlapping functions, thereby complicating the elucidation of
their individual functions.
KNOWN EFFECTORS SECRETED BY
BRUCELLA THROUGH T4SS
Identification of Effectors
Although T4SS was identified in Brucella spp. approximately 15
years ago, the effectors of T4SS remained uncharacterized until
recently. The first two effectors, VirB-co-regulated effector (Vec)
A and VecC, were identified while screening for genes whose
transcription was co-regulated by the virB operon regulator, VjbR
(de Jong et al., 2008). Screening of the interactions between
human proteins and predicted Brucella proteins using a yeast
two hybrid (Y2H) system led to the identification of the Rab2
interacting conserved protein A (RicA)-Rab2 interaction pair.
Subsequently, RicA was identified as a T4SS-dependent effector
(de Barsy et al., 2011). Genome-wide bioinformatics screening
for putative T4SS effector proteins using distinct filtering
criteria led to the identification of nine T4SS-dependent effector
proteins (Marchesini et al., 2011; Myeni et al., 2013). Bacterial
toll-Interleukin receptor (TIR) domain-containing proteins are
thought to be involved in the virulence of Brucella; screening
for TIR-containing proteins in Brucella led to the identification
of two proteins, Brucella TIR protein (Btp) A and BtpB, as
effectors that are translocated by T4SS into host cells (Salcedo
et al., 2013). Recently, a secretory protein, secreted effector
protein A (SepA), which is encoded within a horizontally
transmitted region, was confirmed as a novel T4SS substrate
(Döhmer et al., 2014). Together, these 15 effectors constitute the
FIGURE 1 | The life cycle of Brucella within host cells. During infection, Brucella first invade the host cells (¬), form Brucella-containing vacuoles (BCVs) (­), and
undergo fusion with the lysosome in a controlled manner (®). In this step, about 90% of the Brucella are degraded, and the remaining 10% survive (¯). Then, the BCV
traffic to and reach the endoplasmic reticulum (ER) (°), and establish the replicative site (±). After ER replication, the Brucella traffic toward the autophagy-like
vacuoles (²), survive within these compartments (³), and finally, leave the host cells to promote cell-to-cell spreading (´). The following molecular events involved in
these steps are potentially targeted by T4SS: excluding markers of the late endosome or lysosome, acquiring ER markers, interacting with secretory pathways,
acquiring markers for autophagosomes, resisting the harsh intracellular environment, and regulating the activation of vital immune pathways.
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repertoire of T4SS substrates in Brucella spp. identified to date
(Table 1).
A candidate protein may be identified as a T4SS effector
protein if it fulfills two criteria: the protein must be secreted
into host cells and the secretion must be through the T4SS
machinery. The former may be validated by TEM-1 lactamase
or calmodulin-dependent adenylate cyclase (CyaA) assays and
the latter, by constructing a T4SS-deficient mutant. All strategies
used to identify effectors in Brucella are confined by the limited
number of potential proteins; similar problems were encountered
during the identification of effectors in other bacteria as well.
By extending the screening of potential targets to the whole
genome, the Dot/Icm T4SS machinery of Legionella pneumophila
andCoxiella burnetiiwere identified to secrete approximately 300
and 100 proteins, respectively (Chen et al., 2010; Voth et al., 2011;
Zhu et al., 2011; Lifshitz et al., 2013). Similarly, extending the
screening method described above to the whole Brucella genome
may lead to the identification of many more effectors.
VceA and VceC
Both VceA and VceC, which are composed of 105 and 418
amino acids, respectively, are highly conserved in all Brucella
spp. They share an 18-base pair (bp) conserved promoter box,
similar to the virB promoter, and their transcription is regulated
by the same transcriptional activator, VjbR (de Jong et al., 2008).
Like in the case of the virB promoter, VjbR expressed under
in vitro conditions could bind to DNA fragments containing
the VceC promoter in electrophoretic mobility shift assays
(EMSA). Expression of vceC and virB was downregulated in
B. abortus vjbR mutants, as determined by lacZ fusion and β-
galactosidase activity assays (de Jong et al., 2008), suggesting
that both genes are co-regulated by the same transcriptional
factor.
Analysis of the various domains of VceC revealed that 20
amino acids present at its C-terminus are necessary for its
translocation into host cells, and 38 amino acids present at its
N-terminus, which form a hydrophobic transmembrane domain,
are required for its localization to and perturbation of the
ER (de Jong et al., 2008, 2013). Immunoprecipitation-mass
spectrometry (IP-MS) studies revealed that the ER chaperone
protein, Bip/Grp78, binds to the central proline-rich region of
VceC. This proline-rich region is the only characterized domain
of VceC (de Jong et al., 2013). Consistent with the localization
and identity of its interacting partners inside host cells, VceC
TABLE 1 | The 15 effectors secreted by Brucella through T4SS.
Name ORF in
B. abortus
Amino
acids
Conserved domains Targets
within hosts
Functions Methods References
RicA BAB1_1279 175 Carbonic anhydrase Rab2 Regulating vesicle
trafficking
TEM1 de Barsy et al., 2011;
Nkengfac et al., 2012; Herrou
and Crosson, 2013
VceA BAB1_1652 105 Non Unknown Unknown CyaA, TEM1 de Jong et al., 2008
VceC BAB1_1058 418 The Proline-rich domain Bip/Grp78 Activating Unfolded
Protein Response
CyaA,TEM1 de Jong et al., 2008, 2013
BPE005 BAB1_2005 153 The Coiled-coil domain Unknown Unknown CyaA Marchesini et al., 2011
BPE043 BAB1_1043 1553 The Cyclic nucleotide
binding domain
Unknown Unknown CyaA Marchesini et al., 2011
BPE275 BAB1_1275 253 The Rhomboid-like domain Unknown Unknown CyaA Marchesini et al., 2011
BPE123 BAB2_0123 153 The Apolipoprotein domain Unknown Unknown CyaA Marchesini et al., 2011
BtpA/TcpB/
Btp1
BAB1_0279 250 TIR domain MAL Inhibiting TLR
pathways
CyaA Cirl et al., 2008;
Radhakrishnan et al., 2009;
Radhakrishnan and Splitter,
2010; Sengupta et al., 2010;
Salcedo et al., 2013
BtpB BAB1_0756 292 TIR domain Unknown Inhibiting TLR
pathways
CyaA, TEM1 Salcedo et al., 2013
BspA BAB1_0678 191 The Pfam domain DUF2062 Unknown Inhibiting the
secretory pathway
CyaA, TEM1 Myeni et al., 2013
BspB BAB1_0712 187 The SCOP structural
domain (d2gsaa)
Unknown Inhibiting the
secretory pathway
CyaA, TEM1 Myeni et al., 2013
BspC BAB1_0847 137 The predicted
Sec-dependent signal
peptide
Unknown Unknown CyaA, TEM1 Myeni et al., 2013
BspE BAB1_1671 117 Coiled-coil (CC) and TM
domains
Unknown Unknown CyaA, TEM1 Myeni et al., 2013
BspF BAB1_1948 428 the GNAT-family
acetyltransferase domain
Unknown Inhibiting the
secretory pathway
CyaA, TEM1 Myeni et al., 2013
SepA BAB1_1492 130 Non Unknown Inhibiting BCV fusion
with the lysosome
TEM1 Döhmer et al., 2014
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5 October 2015 | Volume 5 | Article 72
Ke et al. Type IV secretion system of Brucella and effectors
was shown to activate the unfolded protein response (UPS),
cause ER stress, and induce pro-inflammatory responses during
infection. The N-terminal ER-targeting domain of VceC was
found to be involved in the activation of these processes (de Jong
et al., 2013). However, whether the activation of UPS by VceC
contributes to its cytotoxity toward macrophages is not clear
(de Jong et al., 2008). Further studies are required to elucidate
the nature and consequences of the interaction between VceC
and Bip. In addition, the co-regulation of vceC and virB by
VjbR suggests that the expression of virB and its effectors might
be temporally regulated in response to the microenvironment
around the BCVs.
RicA
RicA is a mono-domain protein composed of 175 amino acids
(de Barsy et al., 2011). Extensive mutagenesis studies have
revealed that there are two key elements in RicA, a β-sheet
and an isoleucine-glycine-phenylalanine-proline (IGFP) loop,
both of which are thought to be involved in protein folding
and interaction with Rab2 (Nkengfac et al., 2012). The crystal
structure of RicA revealed that the structure of this protein is
highly similar to those of the γ-carbonic anhydrase (CA) family
of proteins, all of which contain a bound zinc ion. However, RicA
does not possess carbonic anhydrase activity, suggesting that it
may have evolved a unique function that remains to be elucidated
(Herrou and Crosson, 2013).
RicA interacts both in vivo and in vitro with guanosine
diphosphate (GDP)-free and GDP-bound forms of Rab2, but
not with the GTP-bound form, suggesting that RicA is not a
GTPase-activating protein (GAP) (de Barsy et al., 2011; Herrou
and Crosson, 2013). Further assays revealed that this protein does
not function as a guanine nucleotide exchange factor for Rab2.
Whether RicA functions as a GDP dissociation inhibitor or a Rab
escort protein remains to be clarified. A ricA deletion mutant
did not exhibit attenuated virulence in either mice or HeLa
cells. In addition, the internalization and intracellular survival
abilities of the mutant remained unaltered (de Barsy et al., 2011).
Surprisingly, 1ricAmutants showed faster loss of LAMP1 inside
host cells compared with wild-type Brucella (de Barsy et al.,
2011), suggesting that 1ricA mutants escape earlier from late
lysosomes, arrive at the ER, and establish a replicative niche faster
than wild-type bacteria.
BtpA and BtpB
BtpA (also known as Btp1/TcpB) and BtpB share a conserved
TIR-containing domain, which is widely present in mammals
and is responsible for mediating the signaling cascades of innate
immune recognition (Salcedo et al., 2013). Both these proteins
were confirmed to be translocated into host cells, as verified by
the CyaA assay; however, in the widely used TEM-1 lactamase
assay, BtpB showed markedly lower translocating efficiency than
did other effectors or BtpA. However, one must note that the
TEM-1 lactamase assay is less sensitive than the CyaA assay
(Salcedo et al., 2013). Both proteins inhibit the maturation of
dendritic cells and are essential for virulence; however, they show
opposite effects on the activation of NF-κB, with BtpA inhibiting
and BtpB inducing the activation of NF-κB (Salcedo et al., 2008,
2013; Sengupta et al., 2010). The function and mechanism of
action of BtpA has been studied extensively (Cirl et al., 2008;
Radhakrishnan et al., 2009; Radhakrishnan and Splitter, 2010;
Sengupta et al., 2010), and a recent crystal structure revealed
that BtpA specifically targets the host signaling adapter protein,
MyD88 adapter-like (MAL)/TIRAP, through a unique BB loop
region within the TIR domain (Alaidarous et al., 2014; Snyder
et al., 2014).
In order to mediate the inhibition of the host TLR signaling
pathway, BtpA must be translocated into the host cell from
the bacteria; for Brucella, the T4SS machinery is probably the
most efficient system for exerting this translocation. TIR domain-
containing proteins are present in many other bacteria, such
as TlpA in Salmonella enterica, TcpC in Escherichia coli strain
CFT073, TirS in Staphylococcus aureus, YpTdp in Yersinia pestis,
and PdTLP in Paracoccus denitrificans. These proteins also
have the ability to inhibit the toll-like receptor (TLR) pathway
(Newman et al., 2006; Chan et al., 2009; Spear et al., 2009; Rana
et al., 2011, 2013; Snyder et al., 2013; Askarian et al., 2014);
whether or how they are delivered into host cells during infection
remains to be elucidated.
BspA, BspB, and BspF
BspA, BspB, and BspF, together with BspC and BspE, were first
predicted by bioinformatics approaches and then identified by
the TEM-1-fusing protein method (Myeni et al., 2013). BspA,
BspB, and BspF are composed of 191, 187, and 428 amino
acids, and contain the DUF2062 domain (Domain of Unknown
Function 2062, Pfam database), the structural classification of
proteins (SCOP) structural domain (flanked by 2 transmembrane
domains), and the Gcn5-related N-acetyltransferases (GNAT)-
family acetyltransferase domain, respectively (Myeni et al., 2013).
Ectopically expressed BspA and BspB appear to localize at the
ER, while BspF localizes throughout the cytosol and plasma
membrane (Myeni et al., 2013). These three effectors inhibit
the host cells’ protein secretory pathway when overexpressed in
transfected cells, and inhibit cellular secretion during infection
(Myeni et al., 2013). Although deletion of one of these effectors
alone did not impair the replicating abilities of the mutants in
infected BMMs, as determined by enumerating colony forming
units (CFUs), the triple 1bspABF mutant showed decreased
intracellular growth (Myeni et al., 2013). Nevertheless, both
1bspB and 1bspABF mutants displayed a similar replication
deficiency when the percentage of infected cells supporting
bacterial replication and containing at least 10 bacteria were
scored (Myeni et al., 2013). Consistent with these results, in
mice models, the triple 1bspABF mutant partially lost its ability
to survive in the liver, in contrast to the wild-type strain and
the single deletion mutants (Myeni et al., 2013). However,
neither single nor triple deletions of these three effectors
affected the ability to establish systematic infection (Myeni
et al., 2013), suggesting that these effectors exert their effects
only in the later stages of infection and have complementary
functions. Further research on these effectors needs to focus
on the identification of their interacting partners, elucidation of
their biochemical mechanisms, and resolution of their crystal
structures.
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SepA
SepA is a 130-amino acid protein that does not contain any
previously characterized domain. Secretion of SepA occurs in
the very early stages of infection (as early as 30min post-
infection), in a T4SS-dependent manner (Döhmer et al., 2014).
However, strikingly, SepA is not directly delivered into host cells.
Instead it goes through a periplasm-aggregating intermediate
stage before leaving the bacterium, unlike other effectors secreted
by bacterial T4SS or T3SS (Döhmer et al., 2014). A 1sepA
mutant exhibited slightly diminished replicating ability 48 h post-
infection in infected macrophages, and dramatically decreased
replicating ability in the first 4–24 h post-infection, suggesting
that SepA is involved in the initial stages of intracellular survival,
consistent with its early secretion (Döhmer et al., 2014). The
absence of attenuation in the 1sepA mutant might be because
other effectors have similar functions. As the intracellular cycle
of Brucella proceeds, the effects of SepA deficiency may be
rescued by these effectors, resulting in attenuation at the initial
stages and recovery at later stages. Interestingly, although the
1sepA mutant was as virulent as the wild-type strain, a SepA-
overexpressing mutant was found to be attenuated, indicating
that the expression of SepA is tightly regulated (Döhmer
et al., 2014). Because the other effectors exert their effects
in the later stages of the intracellular lifecycle of Brucella,
early secretion is a unique feature of SepA. Therefore, sepA
mutants may be used to study the early stages of infection by
Brucella.
Other Effectors
BspC, BspE, BPE123, BPE005, BPE275, and BPE043 were
identified as effectors after experimental validation of potential
proteins as described above. Although they are highly conserved
among the Brucella, little is known about their roles and
mechanisms of action. When expressed ectopically, both
BspC and BspE localize around the cell nucleus, but with
some differences; the former possibly co-localizes with the
Golgi apparatus but the latter forms discrete vesicles (Myeni
et al., 2013). BspC contains an N-terminal Sec-dependent
signal peptide and can induce an ER stress response without
affecting the protein secretion pathway (Myeni et al., 2013).
BPE005, BPE275, and BPE043 are widely found in other
kinds of bacteria, and BPE123 is present in several species,
including Bartonella bacilliformis, Ochrobactrum anthropi, and
O. intermedium (Marchesini et al., 2011). BPE123 is positioned
at the surface of the BCV during infection. Twenty-five amino
acids located at the N-terminus of the protein might function
as a signal sequence for its translocation into the host cell
(Marchesini et al., 2011). The multiplication abilities of BPE123-
deficient and wild-type strains were found to be indistinguishable
in several cell types and mouse models (Marchesini et al.,
2011).
FUTURE PERSPECTIVE
The identification of the effectors secreted by Brucella will enable
the elucidation of the functions and mechanism of action of
T4SS. In addition, it facilitates the comparison of the various
roles of T4SS among gram-negative bacteria. Effectors secreted
by T4SS from different bacteria, albeit with similar sequences,
may display distinct structures, functions, and mechanisms,
contributing to diverse bacterial pathogenesis. Because Brucella
is used as a model organism to study intracellular infections,
studying the effectors from this species might provide insights
into the functioning of T4SS in intracellular bacteria, which may,
in turn, aid in understanding the pathogenesis of intracellular
bacterial pathogen.
Compared to other bacteria, studies on Brucella T4SS are
limited in number, partly because the effectors were identified
only recently. On the basis of the information available on the
pathogenesis of Brucella, we believe that the following aspects
should be considered in future studies: (1) characterization
of the biochemistry of these effectors, including identification
of the binding targets within host cells, elucidation of the
biochemical mechanisms underlying their action on targets,
investigations on whether they contain featured domains or
novel enzymatic activities such as kinase or phosphatase activities
etc., and their intracellular co-localization with binding partners
when ectopically expressed or injected during infection; (2)
characterization of the cell biology of these effectors, including
their effects on intracellular persistence, intracellular apparatus
or cytoplasmic membrane docking, signaling pathways targeted
by them, and regulation of BCV trafficking [including evading
fusion with lysosomes, arriving at ERs, moving to autophagic
compartments, and spreading into neighboring cells (see
Figure 1)]; (3) elucidation of the contribution of these effectors
to virulence in vivo, including their necessity, roles in establishing
systematic infection, processing during chronic infection, or
eliciting inflammatory response, and whether these effectors
can explain the typical intracellular survival performance of
Brucella species; (4) investigation of effector microevolution,
including similarities and diversities among closely associated
species, distribution of homologs in other intracellular
bacterial pathogens, horizontal transfer among bacteria,
and conservation of function or structure with proteins in other
bacteria.
In past decades, our knowledge of vacuolar trafficking of
eukaryotic cells has significantly advanced; as a result, cues and
tools to explore the intracellular life style of Brucella spp. are now
available. Here, on the basis of the information available on the
pathogenesis of Brucella and the roles of its T4SS outlined above
and elsewhere (Atluri et al., 2011; Martirosyan et al., 2011; Bargen
et al., 2012), we suggest that the following events are targeted by
the 15 effectors of Brucella during infection (Figure 1): acquiring
or losing markers for late endosomes, ERs, or autophagosomes;
resisting and surviving the harsh microenvironment; hijacking
and utilizing the secretory pathways of the ER and the Golgi; and
usurping or regulating the innate immune response. Analyzing
the roles of all 15 effectors in these cascades will further our
understanding of Brucella pathogenesis.
Effectors that are translocated into host cells by bacteria
provide an interface between the bacterium and the host, and
lie in the frontline of the battle between the two. Studying the
effectors is not only important for understanding bacterial
pathogenesis but also provides insights into the immune
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response of eukaryotic hosts. The lack of an adequate immune
response is one of the primary reasons for the inability of the
host to overcome the Brucella infection (Martirosyan et al., 2011;
Bargen et al., 2012). Therefore, studying the effectors secreted
by Brucella might provide insights into the mechanisms by
which this intracellular bacterium specifically hijacks the host
immune signaling pathways. Knowledge of these mechanisms
will help develop better vaccines and therapies against
Brucella.
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